Holding(s) in Company

RNS Number : 3872N
Dechra Pharmaceuticals PLC
25 July 2014
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

DECHRA PHARMACEUTICALS PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):



3. Full name of person(s) subject to the
notification obligation:
iii

FMR LLC

4. Full name of shareholder(s)
 (if different from 3.):iv

See Section 9

5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

24th July 2014

6. Date on which issuer notified:

25th July 2014

7. Threshold(s) that is/are crossed or
reached:
vi, vii

10%



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Indirect

Direct xi

Indirect xii

Direct

Indirect

GB0009633180

8,776,091

8,776,091

8,761,091


8,761,091


9.98%



B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 





 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

8,761,091

9.98%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

Custodian

Day to Day IM

Total

BROWN BROTHERS HARRIMAN AND CO

FMRC-FMR CO., INC

4,575,833

JPMORGAN CHASE BANK

FMR UK-FIDELITY MANAGEMENT & RESEARCH (U.K.) INC.

438,095


FMRC-FMR CO., INC

1,170,800

NORTHERN TRUST CO (C)

FMRC-FMR CO., INC

415,700

STATE STREET BANK AND TR CO

FMRC-FMR CO., INC

2,160,663

Grand Total


8,761,091


Proxy Voting:

10. Name of the proxy holder:

FMR LLC

11. Number of voting rights proxy holder will cease to hold:

15,000

12. Date on which proxy holder will cease to hold voting rights:

24th July 2014



13. Additional information:


None

14. Contact name:

Nina Collomosse

15. Contact telephone number:

 

fil-regreporting@fil.com, 01737 837092

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFMGZNFKMGDZM
UK 100

Latest directors dealings